Research Topics
| M D CreininSummaryAffiliation: University of Pittsburgh Country: USA Publications
| Collaborators
|
Detail Information
Publications
Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectivenessElizabeth G Raymond
Family Health International, Research Triangle Park, NC, USA
BMC Med Res Methodol 4:23. 2004..The objective of this analysis was to explore characteristics of participants who failed to complete seven months of planned participation in a trial of spermicide efficacy...
Effect of nonsteroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortionM D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee Womens Hospital, PA 15213 3180, USA
Contraception 56:165-8. 1997..Use of a nonsteroidal anti-inflammatory drug does not interfere with the action of misoprostol to induce uterine contractions and pregnancy expulsion in women receiving methotrexate and misoprostol for early abortion...
How regular is regular? An analysis of menstrual cycle regularityMitchell D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee Womens Research Institute, 300 Halket Street, Pittsburgh, PA 15213 3180, USA
Contraception 70:289-92. 2004..This variation may have clinical impact on contraceptive practice, contraceptive research studies and pregnancy-related care...
The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiolMitchell D Creinin
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, USA
Contraception 66:147-52. 2002..Significantly greater follicular activity was observed after an extended pill-free interval in women taking LNG/EE compared to those taking triphasic NGM/EE. The clinical implications of these findings require further study...
The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortionMitchell D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, PA 15213, USA
Contraception 71:26-30. 2005....
Mifepristone 100 mg in abortion regimensM D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Obstet Gynecol 98:434-9. 2001..To examine the clinical efficacy of mifepristone 100 mg followed 2 days later by misoprostol 400 microg orally or 800 microg vaginally in women at up to 49 days' gestation...
A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortionMitchell D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, Pennsylvania 15213 3180, USA
Obstet Gynecol 103:851-9. 2004..To demonstrate equivalence between mifepristone 200 mg followed 6 to 8 hours later and 24 hours later by misoprostol 800 microg vaginally for abortion in women up to 63 days of gestation...
Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortionM D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee Womens Hospital, Pittsburgh, PA 15213 3180, USA
Contraception 62:117-24. 2000..In women who did not have a strong preference between medical and surgical abortion, the side effect profile and patient acceptability was significantly better for surgical abortion compared to medical abortion...
Current medical abortion careMitchell D Creinin
University of Pittsburgh, Magee Womens Hospital, 300 Halket Street, Pittsburgh, PA 15213 3180, USA
Curr Womens Health Rep 3:461-9. 2003..Women can self-administer the misoprostol, with complete abortion rates exceeding 95%. Researchers continue to refine the available regimens to improve outcomes and acceptability...
Screening for factor V Leiden mutation before prescribing combination oral contraceptivesM D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee Womens Hospital, Pennsylvania 15213 3180, USA
Fertil Steril 72:646-51. 1999..To evaluate the cost-effectiveness of screening for factor V Leiden mutation in women in the United States who use combination oral contraceptives...
Conception rates after abortion with methotrexate and misoprostolM D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee Womens Hospital, PA, USA
Int J Gynaecol Obstet 65:183-8. 1999..To evaluate the fertility of a cohort of women within 1 year after receiving methotrexate and misoprostol for early abortion...
A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortionM D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee Womens Hospital, Pennsylvania 15213 3180, USA
Contraception 59:11-6. 1999..This trial demonstrates the importance of prospective, randomized studies to prove the relative efficacy of any medical abortion treatment regimen...
Medical abortion with methotrexate 75 mg intramuscularly and vaginal misoprostolM D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee Womens Hospital, PA 15213 3180, USA
Contraception 56:367-71. 1997..This preliminary evaluation demonstrates that a medical abortion regimen using 75 mg methotrexate intramuscularly appears to have similar effectiveness to one with 50 mg/m2 methotrexate...
Endometrial thickness after misoprostol use for early pregnancy failureM D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, PA, USA
Int J Gynaecol Obstet 86:22-6. 2004..To assess if there was any potential relationship between endometrial thickness and final treatment outcome in women successfully treated with misoprostol for a first trimester anembryonic gestation, embryonic demise or fetal demise...
Mifepristone followed on the same day by vaginal misoprostol for early abortionH C Pymar
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, PA 15213-3180, USA
Contraception 64:87-92. 2001..This pilot study suggests that mifepristone 200 mg, followed on the same day by misoprostol 800 microg vaginally, effects abortion at rates comparable to regimens using the standard time interval of 48 h between medications...
Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: report of a randomised trialM D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Hospital, Pennsylvania 15213-3180, USA
BJOG 108:469-73. 2001....
Endometrial thickness following medical abortion is not predictive of subsequent surgical interventionM F Reeves
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Ultrasound Obstet Gynecol 34:104-9. 2009..To evaluate the ability of endometrial thickness after medical abortion to predict the need for subsequent dilatation and curettage (D&C)...
Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortionMitchell D Creinin
Department of Obstetrics, Gynecology, and Women's Health, University of Pittsburgh Physicians, PA, USA
Am J Obstet Gynecol 188:664-9. 2003..CONCLUSION: Medical abortion with mifepristone/misoprostol and with methotrexate/misoprostol can be provided in a nonresearch setting with efficacy similar to that reported in the medical literature for research protocols...
Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot studyPatricia A Lohr
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
Contraception 76:215-20. 2007..This pilot study sought to determine if a simultaneous regimen using buccal misoprostol would be similarly effective and merit further investigation...
Multicenter comparison of the contraceptive ring and patch: a randomized controlled trialMitchell D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences and Magee Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213 3180, USA
Obstet Gynecol 111:267-77. 2008..To understand if the contraceptive ring or patch was more acceptable, as measured primarily by continuation, to women using an oral contraceptive and interested in a nondaily, combined hormonal contraceptive...
A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestationAmitasrigowri S Murthy
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, PA 15213, USA
Contraception 71:333-6. 2005..CONCLUSION: Simultaneous administration of mifepristone and vaginal misoprostol is a promising regimen for medical abortion up to 49 days gestation...
Medical abortion outcomes after a second dose of misoprostol for persistent gestational sacMatthew F Reeves
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
Contraception 78:332-5. 2008..We sought to examine outcomes after a second dose of misoprostol was given at a 1-week follow-up visit after medical abortion for the presence of a persistent gestational sac (GS) on ultrasound examination...
Factors related to successful misoprostol treatment for early pregnancy failureMitchell D Creinin
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, and Magee Womens Research Institute, Pittsburgh, Pennsylvania 15213 3180, USA
Obstet Gynecol 107:901-7. 2006..To identify potential predictors for treatment success in medical management with misoprostol for early pregnancy failure...
Feasibility of telephone follow-up after medical abortionLisa K Perriera
University of Pittsburgh School of Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, Pittsburgh, PA 15213, USA
Contraception 81:143-9. 2010..This study was conducted to assess the feasibility of using telephone calls combined with high-sensitivity urine pregnancy testing as a primary method of follow-up after medical abortion...
Predicting risk of ovulation in new start oral contraceptive usersJill L Schwartz
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, Pennsylvania 15213-3180, USA
Obstet Gynecol 99:177-82. 2002..2). CONCLUSION: Although a delay in oral contraceptive initiation results in significantly more ovarian follicular development, the postponement does not appear to increase actual ovulation rates...
Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortionBrooke Rossi
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, 300 Halket Street, Pittsburgh, PA 15213-3180, USA
Contraception 70:313-7. 2004..1% (95% CI: 98.2-99.6) of cases. Women and clinicians are very accurate at determining expulsion of gestational sac during medical abortion with mifepristone and misoprostol without ultrasonography or a physical examination...
Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trialMitchell D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences and Magee Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213 3180, USA
Obstet Gynecol 109:885-94. 2007....
Sexual function in first-time contraceptive ring and contraceptive patch usersClarisa R Gracia
Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Fertil Steril 93:21-8. 2010..To assess sexual function of first-time users of the contraceptive ring and contraceptive patch...
The trimonthly combination oral contraceptive regimen: is it cost effective?J L Schwartz
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee Womens Hospital, Pennsylvania 15213 3180, USA
Contraception 60:263-7. 1999..20. Therefore, the trimonthly regimen may be useful for women with menorrhagia, but for the average women, the qualitative benefits of less frequent withdrawal bleeding need to be weighed against an increase in cost...
Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trialCourtney A Schreiber
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, PA 15213, USA
Contraception 74:458-62. 2006....
Medical management of early pregnancy failure in a patient with coronary artery diseaseDavid N Hackney
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
Fertil Steril 88:212.e1-3. 2007..To describe a case of early pregnancy failure in a patient who was not an optimal candidate for suction aspiration because of her body habitus and history of a myocardial infarction that was treated medically with misoprostol...
Oral contraceptives and breakthrough bleeding: what patients need to knowPatricia A Lohr
University of Pittsburgh, Magee-Womens Hospital, 300 Halket Street, Pittsburgh, PA 15213-3180, USA
J Fam Pract 55:872-80. 2006
The contraceptive implantHeather Hohmann
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
Clin Obstet Gynecol 50:907-17. 2007..Implanon has been shown to be safe to use during lactation, may improve dysmenorrhea, and does not significantly affect bone mineral density, lipid profile, or liver enzymes...
Women's motivation to participate in contraceptive efficacy trialsHeather Hohmann
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee Women s Hospital, Pittsburgh, PA 15213, USA
Contraception 80:270-5. 2009..We sought to determine whether there are differences in subject's motivation to participate in hormonal and barrier method contraceptive efficacy studies...
Contraceptive effectiveness of immediate compared with delayed insertion of intrauterine devices after abortion: a decision analysisMatthew F Reeves
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine and the Magee Womens Research Institute, Pittsburgh, Pennsylvania 15213 3180, USA
Obstet Gynecol 109:1286-94. 2007..To model rates of pregnancy and repeat abortion among women choosing intrauterine contraception after an abortion when the intrauterine device (IUD) is inserted immediately after the procedure or at a follow-up visit...
Pharmacoeconomics of medical abortion: a review of cost in the United States, Europe and AsiaAmitasrigowri Murthy
Department of Obstetrics, Gynaecology and Reproductive Sciences, University of Pittsburgh School of Medicine Magee Womens Hospital, 300 Halket Street, Pittsburgh, PA 15261, USA
Expert Opin Pharmacother 4:503-13. 2003..Following the cost analysis, there is a summary of relevant information from countries in Europe, primarily the UK, France, Sweden and countries in Asia, mainly China and India...
Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestationMichelle C Fox
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, PA, USA
Contraception 66:225-9. 2002..Though this regimen is promising, larger randomized trials comparing it to standard regimens are needed before widespread use...
A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 daysCourtney A Schreiber
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, PA 15213, USA
Contraception 71:447-50. 2005....
Psychiatric outcomes following medical and surgical abortionDorothy Sit
Department of Psychiatry, University of Pittsburgh School of Medicine, PA 15213, USA
Hum Reprod 22:878-84. 2007..The objectives were to determine post-abortion depression risk, evaluate risk factors for post-abortion depression and to explore the relationship between cortisol and depression...
Accuracy of serum beta-human chorionic gonadotropin cutoff values at 42 and 49 days' gestationM D Creinin
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, PA, USA
Am J Obstet Gynecol 185:966-9. 2001..CONCLUSION: Serum beta-human chorionic gonadotropin values can be used with reasonable accuracy to screen for a gestational age up to 49 days' gestation...
Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trialBeatrice A Chen
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
Obstet Gynecol 116:1079-87. 2010..To estimate whether 6-month use of the levonorgestrel-releasing intrauterine device (IUD) would be higher when insertion occurred within 10 minutes of placental delivery compared with 6-8 weeks postpartum...
Doxycycline serum levels at the time of dilation and evacuation with two dosing regimensMatthew F Reeves
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, and Magee Women s Research Institute, Pittsburgh, PA 15213, USA
Contraception 79:129-33. 2009..Taking doxycycline the night prior to surgery may result in adequate absorption with better tolerance...
Contemporary management of early pregnancy failureBeatrice A Chen
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA
Clin Obstet Gynecol 50:67-88. 2007..Clinicians need to understand how these options compare to provide appropriate counseling to patients...
Can we communicate gravidity and parity better?Mitchell D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences and Magee Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213 3180, USA
Obstet Gynecol 113:709-11. 2009..In this article, we discuss the pitfalls of current systems used for describing a woman's reproductive history and recommend new and simple nomenclature to enhance our ability to communicate properly...
Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failureMatthew F Reeves
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Obstet Gynecol 111:106-12. 2008..We sought to compare endometrial thickness after misoprostol or dilation and curettage (D&C) for early pregnancy failure and to assess the predictive value of endometrial thickness for subsequent D&C after misoprostol treatment...
Interest in intrauterine contraception among seekers of emergency contraception and pregnancy testingEleanor Bimla Schwarz
Center for Research on Health Care, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
Obstet Gynecol 113:833-9. 2009..To estimate the interest in using intrauterine contraception among women and adolescent girls seeking emergency contraception or walk-in pregnancy testing...
The risks of oral contraceptive pillsH C Pymar
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee-Women's Research Institute, Pittsburgh, Pennsylvania, USA
Semin Reprod Med 19:305-12. 2001..However, because the incidence of breast cancer is so low in this population, the attributable risk of breast cancer from birth control pill use is small...
Toxic shock syndrome after laminaria insertionG Sutkin
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Hospital, Pittsburgh, Pennsylvania, USA
Obstet Gynecol 98:959-61. 2001..Laminaria tents used to facilitate surgical abortion are rarely associated with significant infectious morbidity...
The prevalence of domestic violence in volunteers for abortion and contraceptive research studiesSofia Kazi
University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
Contraception 78:79-83. 2008..We hypothesize that participants in research studies would report similar rates of abuse to women in the general population and that subjects in abortion studies would report higher rates of abuse than women in other gynecologic studies...
Medical management of early pregnancy failure: efficacyBeatrice A Chen
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
Semin Reprod Med 26:411-22. 2008..Clinicians need to understand the range of efficacy of these regimens to provide appropriate counseling to patients...
Effects of long-term use of nonoxynol-9 on vaginal floraCourtney A Schreiber
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, Pennsylvania, USA
Obstet Gynecol 107:136-43. 2006..This longitudinal study was conducted to examine the effects of nonoxynol-9 on the vaginal ecology...
Misoprostol for treatment of early pregnancy failure in women with previous uterine surgeryBeatrice A Chen
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, and Magee Womens Research Institute, Pittsburgh, PA, USA
Am J Obstet Gynecol 198:626.e1-5. 2008..Misoprostol use in early pregnancy may incur a risk of uterine rupture in women with previous uterine surgery...
Training and attitudes about contraceptive management across primary care specialties: a survey of graduating residentsCourtney A Schreiber
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
Contraception 73:618-22. 2006..The objective of this study was to analyze survey data from physicians in primary care training programs in Pittsburgh, PA...
Same-day initiation of the transdermal hormonal delivery system (contraceptive patch) versus traditional initiation methodsAmitasrigowri S Murthy
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine/Magee Womens Research Institute, Pittsburgh, PA 15213, USA
Contraception 72:333-6. 2005..0). Only approximately half of the subjects planned to continue using the patch after the study. CONCLUSION: Quick Start for the contraceptive patch did not improve continuation rates into the second or third cycle...
Progesterone receptor modulator for emergency contraception: a randomized controlled trialMitchell D Creinin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh and Magee Womens Research Institute, Pittsburgh, Pennsylvania 15213, USA
Obstet Gynecol 108:1089-97. 2006..Compare the efficacy and adverse effects of CDB-2914, a new progesterone receptor modulator, to levonorgestrel for emergency contraception...
Low-dose fentanyl and midazolam in outpatient surgical abortion up to 18 weeks of gestationLeah C Wilson
Department of Obstetrics, Gynecology and Reproductive Sciences, Magee Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
Contraception 79:122-8. 2009..We investigated the safety of a conscious sedation protocol using intravenous fentanyl and midazolam by direct venous injection in women who underwent outpatient surgical abortion up to 18 weeks of gestation...
Contraception services for incarcerated women: a national survey of correctional health providersCarolyn B Sufrin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94110, USA
Contraception 80:561-5. 2009..Incarcerated women have had limited access to health care prior to their arrest. Although their incarceration presents an opportunity to provide them with health care, their reproductive health needs have been overlooked...
Incarcerated women and abortion provision: a survey of correctional health providersCarolyn B Sufrin
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA, USA
Perspect Sex Reprod Health 41:6-11. 2009..However, the availability of abortion services to inmates in the United States is unknown...
Feasibility study of the use of a daily electronic mail reminder to improve oral contraceptive complianceMichelle C Fox
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, PA, USA
Contraception 68:365-71. 2003..Because inconsistent OCP use is a significant cause of unplanned conception, the use of e-mail to improve OCP compliance has the potential to decrease unintended pregnancies...
Complication rates and utility of intravenous access for surgical abortion procedures from 12 to 18 weeks of gestationChristina M Racek
University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
Contraception 82:286-90. 2010....
Enzymatic removal of asparagine-linked carbohydrate chains from heterodimer human chorionic gonadotrophin and effect on bioactivityCraig A H Richard
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee Women s Research Institute, Pittsburgh, PA 15213, USA
Reprod Fertil Dev 19:933-46. 2007..These results exemplify a simple and efficient method for creating deglycosylated hCG and provide the most direct evidence for the importance of Asn-linked carbohydrate chains in maintaining hCG bioactivity...
Miscommunication between healthcare providers and patients may result in unplanned pregnancies small star, filledJennifer N Isaacs
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA
Contraception 68:373-6. 2003..Healthcare providers may contribute to the occurrence of unintended pregnancy if they provide poor medical advice or miscommunicate with patients...
Medical management of missed abortion: a randomized clinical trialMitchell D Creinin
Obstet Gynecol 100:382-3. 2002
Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trialAnne R Davis
Columbia University, Department of Obstetrics and Gynecology, 622 West 168th St, PH 16 Room 80, New York, NY 10032, USA
Am J Obstet Gynecol 196:31.e1-7. 2007..The purpose of this study was to describe bleeding patterns after misoprostol or curettage for early pregnancy failure (EPF)...
A comparison of medical management with misoprostol and surgical management for early pregnancy failureJun Zhang
Epidemiology Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892, USA
N Engl J Med 353:761-9. 2005..Misoprostol is increasingly used to treat women who have a failed pregnancy in the first trimester. We assessed the efficacy, safety, and acceptability of this treatment in a large, randomized trial...
A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for first-trimester pregnancy failureJerry M Gilles
University of Miami, Miami, FL, USA
Am J Obstet Gynecol 190:389-94. 2004..59). Five subjects in each group underwent curettage. CONCLUSION: Misoprostol is effective for the treatment of failed first-trimester pregnancy. The expulsion rate is not improved by adding saline solution...
Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trialKurt T Barnhart
University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
Obstet Gynecol 110:577-86. 2007..The objective of this study was to assess the gel's contraceptive effects, safety, and acceptability...
Effect of "observed start" vs. traditional "Sunday start" on hormonal contraceptive continuation rates after medical abortionPaula H Bednarek
Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
Contraception 78:26-30. 2008..quot;..
Induced abortion: an overview for internistsDavid A Grimes
Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7570, USA
Ann Intern Med 140:620-6. 2004..The cost of abortion (currently about 372 dollars at 10 weeks) has decreased in recent decades. Provision of ongoing contraception and encouragement of emergency contraception can reduce unintended pregnancies and the need for abortion...
FemCap with removal strap: ease of removal, safety and acceptabilityChristine K Mauck
CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
Contraception 73:59-64. 2006..This trial assessed whether the new design reduced removal difficulties and had any effects on dislodgment, genital pain/discomfort, safety, and acceptability...
Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labelingLee P Shulman
Department of Obstetrics and Gynecology, Division of Reproductive Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
Contraception 73:440-2. 2006
Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety studyJill L Schwartz
Department of Obstetrics and Gynecology, CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA
Contraception 74:133-40. 2006..Cellulose sulfate (CS) is a noncytotoxic antifertility agent that exhibits in vitro antimicrobial activity against sexually transmitted pathogens, including HIV...
Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragmD Nyce L Williams
CONRAD, Arlington, VA, USA
Sex Transm Dis 34:977-84. 2007..To assess the safety and acceptability of 2 vaginal microbicide gels (Acidform and BufferGel) used with a diaphragm compared to KY Jelly used with a diaphragm among low-risk, sexually abstinent women...
Lea's Shield: colposcopic and microbiological testing during 8 weeks of useChristine K Mauck
CONRAD, Eastern Virginia Medical School, Department of Obstetrics and Gynecology, Arlington, VA 22209, USA
Contraception 72:53-9. 2005....
Acceptability of five nonoxynol-9 spermicidesElizabeth G Raymond
Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA
Contraception 71:438-42. 2005..To examine the acceptability of five nonoxynol-9 (N-9) spermicides...
A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol IIChristine K Mauck
CONRAD, Eastern Virginia Medical School, 1611 North Kent Street, Arlington, VA 22209, USA
Contraception 70:233-40. 2004..C31G is an antimicrobial and spermicidal agent that contains two surface-active compounds, cetyl betaine and myristamine oxide. It is being developed as a vaginal microbicide and contraceptive...
Clinical utility of urine pregnancy assays to determine medical abortion outcome is limitedEmily M Godfrey
Department of Family Medicine, University of Illinois College of Medicine, Chicago, IL 60612, USA
Contraception 75:378-82. 2007..Determining medical abortion outcome commonly includes a costly evaluation such as ultrasonography or serial serum hCG testing. Urine pregnancy testing may represent a less costly alternative...
From American Idol to Plan B: a call for a shift in prioritiesElisa S Wells
Contraception 76:337-8. 2007
Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulationsBryna Harwood
Department of Obstetrics and Gynecology, University of Illinois at Chicago College of Medicine, Chicago, IL, USA
Am J Obstet Gynecol 198:32.e1-7. 2008..This study was undertaken to compare the colposcopic appearance of the cervicovaginal epithelium with spermicide use vs condom use in a low-risk population...
